Terray Therapeutics unveils game-changing platform for drug discovery
Endpoints News - 15-Feb-2022Combining AI with innovative chemistry to tackle the data bottleneck in medicine development
The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.
Editor at Endpoints News
Her coverage varies daily but as a Hong Kong native, she is particularly excited about drug development in China. A graduate of Rice University, her work has appeared in Houstonia Magazine, Governing Magazine and The Chautauquan Daily. Amber is based in Hong Kong.
Details last updated 02-Aug-2020
Combining AI with innovative chemistry to tackle the data bottleneck in medicine development
New gene expression therapy for various targets, with clinical trial planned for 2021